New England PharmAssociates

Excellence in life sciences asset development

NEPA News and Events

5 May 2014 - Roger Frechette moderated a panel discussion at MassBio's 3rd Annual CRO/CMO Symposium addressing challenges and solutions for operating a biotech company using a virtual business model.

The Symposium Agenda entry for this panel:

The Virtual Model - Orchestrating Consultants and Distributed Research Organizations

Moderator: Roger Frechette, Ph.D., Co-Founder and Partner, New England PharmAssociates, LLC


Mary Lynne Hedley, Ph.D. President, TESARO

Doris Peterkin, CEO, ONCoPEP, Inc.

Pam Randhawa, CEO, Empiriko

Albine Martin, Ph.D., COO, Precision Biologics

For more information about the third iteration of this very well received MassBio Signature event, please click here.